ChemPartner is a world-class biologics drug discovery organization with the experience and capabilities to discover, engineer, express, purify, and analyze monoclonal antibodies and recombinant proteins for our clients. Our staff of nearly 200 scientists is led by Western-trained PhDs with decades of pharmaceutical company experience. Our biologics department offers capabilities for large pharmaceutical companies, biotech companies, virtual biotech companies, and academic groups.
The antibody discovery group at ChemPartner develops antibody-drug conjugates, humanized mouse monoclonal antibodies, fully human monoclonal antibodies, and affinity matured monoclonal antibodies. We have also discovered novel high-affinity monoclonal antibodies by hybridoma technology (including human antibodies from mice), B cell cloning technology, and phage display technology.
The protein scientists at ChemPartner are experts in the expression of recombinant proteins in all modern expression systems and the purification of client targets. Although focused on large-scale antibody production, this team is also experienced in supporting integrated programs and customized protein production services.
